New strategies potential to advance immunotherapy in breast cancer

Immunotherapy in breast cancer faces many challenges, but immune biomarkers might help identify which breast tumors will be receptive. Biomarkers better define the patient population who might benefit and, likewise, identify those who are unlikely to respond and need another approach. Dr. Amreen Husain, Genentech’s Immuno-Oncology Global Development Leader, further discusses this potential strategy for breast cancer immunotherapy. Learn more.